Delivery Order SPE2DB22D3004-SPE2DB25FPJ39
Award Date
2/3/25
Potential Completion Date
2/4/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,558.95 firm fixed-price delivery order contract is for the supply of NALBUPHINE 20 MG/ML AMPULML, a pharmaceutical product. The contract has a period of performance through February 20, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award, valued at $1,496.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALBUPHINE 200 MG/10 ML VIAL 10ML, a medical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,036.86 for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 18, 2025, with a completion date of February 19, 2025. This contract represents a small portion of Amerisourcebergen's broader contracting relationship with the federal government, as the company...
This federal contract award, valued at $3,498.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a performance period ending on December 20, 2024. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, valued at $4,237.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567286025 - NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through February 18, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office division, involves the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML pharmaceutical products. The award, valued at $4,561.80, was made by the Defense Logistics Agency (DLA) on August 14, 2024, with a completion date of August 15, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,824.74 firm fixed-price delivery order is for the supply of 10 mL vials of the medication Nalbuphine 200 mg. The contract has a completion date of July 5, 2024 and was awarded on July 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $78,513.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4539361389 units of Nalbuphine 10ML 25S, a pharmaceutical product, with an ultimate completion date of October 13, 2017. The contract is structured as a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen...
The federal contract award is for the delivery of Nalbuphine 100 mg/10 ml vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,473.54 and an ultimate completion date of December 29, 2023. This award is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The specific award is for 4,565,477,002 units of Bupivacaine 0.5% Vial 50ML, a...